2022 AHA/ACC/HFSA guideline for the management of heart failure: a report of the American College of Cardiology/American Heart Association Joint Committee on …

PA Heidenreich, B Bozkurt, D Aguilar, LA Allen… - Journal of the American …, 2022 - jacc.org
Abstract Aim The “2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure”
replaces the “2013 ACCF/AHA Guideline for the Management of Heart Failure” and the …

2023 ACC/AHA/ACCP/HRS guideline for the diagnosis and management of atrial fibrillation: a report of the American College of Cardiology/American Heart …

JA Joglar, MK Chung, AL Armbruster, EJ Benjamin… - Circulation, 2024 - Am Heart Assoc
AIM The “2023 ACC/AHA/ACCP/HRS Guideline for the Diagnosis and Management of Atrial
Fibrillation” provides recommendations to guide clinicians in the treatment of patients with …

Thyroid hormones and cardiovascular function and diseases

S Razvi, A Jabbar, A Pingitore, S Danzi, B Biondi… - Journal of the American …, 2018 - jacc.org
Thyroid hormone (TH) receptors are present in the myocardium and vascular tissue, and
minor alterations in TH concentration can affect cardiovascular (CV) physiology. The …

Circulating heart failure biomarkers beyond natriuretic peptides: review from the Biomarker Study Group of the Heart Failure Association (HFA), European Society of …

WC Meijers, A Bayes‐Genis, A Mebazaa… - European journal of …, 2021 - Wiley Online Library
New biomarkers are being evaluated for their ability to advance the management of patients
with heart failure. Despite a large pool of interesting candidate biomarkers, besides …

[HTML][HTML] Hypothyroidism and the heart

M Udovcic, RH Pena, B Patham… - Methodist DeBakey …, 2017 - ncbi.nlm.nih.gov
Hypothyroidism is a commonly encountered clinical condition with variable prevalence. It
has profound effects on cardiac function that can impact cardiac contractility, vascular …

[HTML][HTML] Deiodinases control local cellular and systemic thyroid hormone availability

J Köhrle, C Frädrich - Free Radical Biology and Medicine, 2022 - Elsevier
Iodothyronine deiodinases (DIO) are a family of selenoproteins controlling systemic and
local availability of the major thyroid hormone l-thyroxine (T4), a prohormone secreted by the …

Thyroid dysfunction in heart failure and cardiovascular outcomes

L Kannan, PA Shaw, MP Morley… - Circulation: Heart …, 2018 - Am Heart Assoc
Background: The effects of thyroid dysfunction in patients with preexisting heart failure have
not been adequately studied. We examined the prevalence of thyroid dysfunction and …

Thyroid and cardiovascular disease: research agenda for enhancing knowledge, prevention, and treatment

AR Cappola, AS Desai, M Medici, LS Cooper, D Egan… - Circulation, 2019 - Am Heart Assoc
Thyroid hormones have long been known to have a range of effects on the cardiovascular
system. However, significant knowledge gaps exist concerning the precise molecular and …

Thyroid disorders and cardiovascular manifestations: an update

SA Paschou, E Bletsa, PK Stampouloglou, V Tsigkou… - Endocrine, 2022 - Springer
Cardiovascular disease (CVD) remains the leading cause of death worldwide, representing
a major health, social, and economic issue. Thyroid disorders are very common and affect> …

[HTML][HTML] Cardiotoxicity with vascular endothelial growth factor inhibitor therapy

RM Touyz, J Herrmann - NPJ Precision Oncology, 2018 - nature.com
Angiogenesis inhibitors targeting the vascular endothelial growth factor (VEGF) signaling
pathway (VSP) have been important additions in the therapy of various cancers, especially …